Meitner S
Based on image analysis, the co-localization area of Golgi and nanocarriers was limited (Fig S8b)
Therefore, there should be no notable differences in terms of quality or effectiveness between generic and brand-name versions of Xanax or any other medication
We know how complex obesity and obesogenic environments are, and efforts to address obesity should not prioritize medications but rather consider the complex holistic and systemic changes in health environments, lifestyle factors, etc, to derive more sustainable benefits. Careful patient selection is also critical
GLP-1 as a target for therapeutic intervention
Digestive Issues Women with Lipedema already have higher rates of: IBS Constipation Bloating SIBO (small intestinal bacterial overgrowth) Slow digestion GLP-1s slow gastric emptying even further, which can increase: Constipation Gastroparesis Reflux Nausea If digestive issues are present, they ideally should be addressed before starting GLP-1s